Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

96.78
+0.09000.09%
Volume:146.55K
Turnover:14.18M
Market Cap:24.31B
PE:-12.45
High:97.32
Open:97.24
Low:96.22
Close:96.69
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:0.28
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.19
PE(LYR):-17.54

Loading ...

Pfizer and BioNTech Lock In Next-Gen Pediatric COVID Booster Edge

TIPRANKS
·
Aug 07

European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading

MT Newswires Live
·
Aug 06

Downgrade: Here's How Analysts See BioNTech SE (NASDAQ:BNTX) Performing In The Near Term

Simply Wall St.
·
Aug 06

BioNTech is Maintained at Buy by Citigroup

Dow Jones
·
Aug 06

Shionogi Advances Phase 3 Secutrelvir Trial, Eyeing New COVID-19 Market Upside

TIPRANKS
·
Aug 06

Wells Fargo Remains a Buy on BioNTech SE (BNTX)

TIPRANKS
·
Aug 05

Berenberg Bank Adjusts BioNTech SE Price Target to $132 From $140, Maintains Buy Rating

MT Newswires Live
·
Aug 05

Analysts Are Bullish on Top Healthcare Stocks: BioNTech SE (BNTX), Pfizer (PFE)

TIPRANKS
·
Aug 05

BioNTech Se : Berenberg Cuts Target Price to $132 from $140

THOMSON REUTERS
·
Aug 05

Germany's Fresenius Raises 2026 Core EPS Growth Guidance

Reuters
·
Aug 05

Jefferies Sticks to Their Buy Rating for BioNTech SE (BNTX)

TIPRANKS
·
Aug 05

Bernstein Sticks to Their Hold Rating for BioNTech SE (BNTX)

TIPRANKS
·
Aug 05

Energean Director Boosts Stake with Share Purchase

TIPRANKS
·
Aug 04

BioNTech's New CEO Will Need Time to Improve Portfolio

Dow Jones
·
Aug 04

Biontech SE Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

BioNTech Lowers 2026 Sales Outlook as COVID Vaccine Demand Softens

Reuters
·
Aug 04

Why Pfizer Stock and This Covid Vaccine Partner are Falling on Earnings

Dow Jones
·
Aug 04

Biontech Appoints Guido Oelkers as CEO Effective by February 1, 2027

Reuters
·
Aug 04

BioNTech Q2 Revenue EUR 105.6 Million

Reuters
·
Aug 04

GUIDANCE: (BNTX) BioNTech Expects 2026 Revenue Range 1.60B Euros - 1.90B Euros, vs. FactSet Est of 2.16B Euros

MT Newswires Live
·
Aug 04